Form 8.3 - [Abbvie. Inc]
April 07 2020 - 09:52AM
Dow Jones News
TIDM0QCV TIDM0Y7T
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997,
TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING
1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) State Street Global Advisors &
Affiliates
--------------------------------------------- -------------------------------
Company dealt in AbbVie Inc.
--------------------------------------------- -------------------------------
Class of relevant security to which US$0.01 common stock
the dealings being disclosed relate (Note 2)
--------------------------------------------- -------------------------------
Date of dealing 06(th) April 2020
--------------------------------------------- -------------------------------
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of
relevant security dealt in (Note 3)
Long Short
------------------------------------- -------------------- -----------
Number (%) Number (%)
------------------------------------- ---------- -------- ------ ---
(1) Relevant securities 69,016,937 4.67381%
------------------------------------- ---------- -------- ------ ---
(2) Derivatives (other than options) N/A
------------------------------------- ---------- -------- ------ ---
(3) Options and agreements to
purchase/sell N/A
------------------------------------- ---------- -------- ------ ---
Total 69,016,937 4.67381%
------------------------------------- ---------- -------- ------ ---
(b) Interests and short positions in relevant securities of the company,
other than the class dealt in (Note 3)
Class of relevant security: Long Short
------------------------------------------- ----------- -----------
Number (%) Number (%)
------------------------------------------- ------ --- ------ ---
(1) Relevant securities N/A
------------------------------------------- ------ --- ------ ---
(2) Derivatives (other than options) N/A
------------------------------------------- ------ --- ------ ---
(3) Options and agreements to purchase/sell N/A
------------------------------------------- ------ --- ------ ---
Total N/A
------------------------------------------- ------ --- ------ ---
3. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit (Note 5)
-------------- ----------------------------- -----------------------
Purchase 600 75.78
-------------- ----------------------------- -----------------------
Purchase 300 75.73
-------------- ----------------------------- -----------------------
Purchase 4,800 75.73
-------------- ----------------------------- -----------------------
Purchase 1,900 75.73
-------------- ----------------------------- -----------------------
Purchase 51,700 75.27
-------------- ----------------------------- -----------------------
Purchase 279 75.73
-------------- ----------------------------- -----------------------
Purchase 6,700 75.99
-------------- ----------------------------- -----------------------
Purchase 1,000 76.36
-------------- ----------------------------- -----------------------
Purchase 135 75.73
-------------- ----------------------------- -----------------------
Purchase 511 75.73
-------------- ----------------------------- -----------------------
Purchase 330 75.73
-------------- ----------------------------- -----------------------
Purchase 280,924 75.73
-------------- ----------------------------- -----------------------
Purchase 12,402 75.73
-------------- ----------------------------- -----------------------
Purchase 728 75.73
-------------- ----------------------------- -----------------------
Purchase 51 75.73
-------------- ----------------------------- -----------------------
Purchase 117 75.73
-------------- ----------------------------- -----------------------
Purchase 18,000 75.73
-------------- ----------------------------- -----------------------
Purchase 970 75.73
-------------- ----------------------------- -----------------------
Purchase 267 75.73
-------------- ----------------------------- -----------------------
Purchase 570 75.73
-------------- ----------------------------- -----------------------
Sale 72 75.69
-------------- ----------------------------- -----------------------
Sale 1,900 75.73
-------------- ----------------------------- -----------------------
Sale 7,700 75.73
-------------- ----------------------------- -----------------------
Sale 500 75.73
-------------- ----------------------------- -----------------------
Sale 7,952 75.73
-------------- ----------------------------- -----------------------
Sale 17,556 75.73
-------------- ----------------------------- -----------------------
Sale 515 75.74
-------------- ----------------------------- -----------------------
Sale 6,790 75.73
-------------- ----------------------------- -----------------------
Sale 7,760 76.00
-------------- ----------------------------- -----------------------
Sale 1,300 75.42
-------------- ----------------------------- -----------------------
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant securities Price per unit
e.g. CFD (Note 6) (Note 7) (Note 5)
------------- --------------------- ----------------------------- --------------
N/A
------------- --------------------- ----------------------------- --------------
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, Writing, selling, Number of Exercise Type, e.g. Expiry Option money
e.g. call option purchasing securities to which price American, date paid/received
varying etc. the option relates European etc. per unit (Note 5)
(Note 7)
----------------- ----------------- -------------------- -------- -------------- ------ ------------------
N/A
----------------- ----------------- -------------------- -------- -------------- ------ ------------------
(ii) Exercising
Product name, Number of securities Exercise price per
e.g. call option unit (Note 5)
----------------- -------------------- ------------------
N/A
----------------- -------------------- ------------------
(d) Other dealings (including transactions in respect of new securities)
(Note 4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
--------------------- ------- -------------------------
N/A
--------------------- ------- -------------------------
4. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or
derivatives
Full details of any agreement, arrangement or understanding
between the person disclosing and any other person
relating to the voting rights of any relevant securities
under any option referred to on this form or relating
to the voting rights or future acquisition or disposal
of any relevant securities to which any derivative
referred to on this form is referenced. If none, this
should be stated.
-----------------------------------------------------------
N/A
-----------------------------------------------------------
Is a Supplemental Form 8 attached? (Note 9) NO
------------------------------------------------------- -----------------
Date of disclosure 07(th) April 2020
------------------------------------------------------- -----------------
Contact name Lionel Colaco
------------------------------------------------------- -----------------
Telephone number 020 33956098
------------------------------------------------------- -----------------
If a connected EFM, name of offeree/offeror with which N/A
connected
------------------------------------------------------- -----------------
If a connected EFM, state nature of connection (Note N/A
10)
------------------------------------------------------- -----------------
(END) Dow Jones Newswires
April 07, 2020 09:37 ET (13:37 GMT)
Copyright (c) 2020 Dow Jones & Company, Inc.
Allergan (NYSE:AGN)
Historical Stock Chart
From Feb 2024 to Mar 2024
Allergan (NYSE:AGN)
Historical Stock Chart
From Mar 2023 to Mar 2024